Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions

被引:33
作者
Douet-Guilbert, Nathalie [2 ,3 ,5 ]
Basinko, Audrey [2 ,3 ,4 ]
Morel, Frederic [2 ,3 ,5 ]
Le Bris, Marie-Josee [3 ]
Ugo, Valerie [4 ,5 ]
Morice, Patrick [6 ]
Berthou, Christian [7 ]
De Braekeleer, Marc [1 ,2 ,3 ,5 ]
机构
[1] Univ Bretagne Occidentale, Fac Med & Sci Sante, Lab Cytogenet, F-29238 Brest 3, France
[2] Univ Bretagne Occidentale, Fac Med & Sci Sante, Lab Histol Embryol & Cytogenet, F-29238 Brest, France
[3] CHU Brest, Hop Morvan, Serv Cytogenet Cytol & Biol Reprod, F-29285 Brest, France
[4] CHU Brest, Hop Morvan, Lab Hematol Biol, F-29285 Brest, France
[5] Inst Natl Sante & Rech Med, INSERM, U613, Brest, France
[6] CH Yves Foll, Serv Hematol, St Brieuc, France
[7] CHU Brest, Hop Morvan, Inst Cancerol & Hematol, Ser Hematol Clin, F-29285 Brest, France
关键词
myelodysplastic syndromes; myeloproliferative disorders; chromosome; 20; deletion; FISH;
D O I
10.1007/s00277-008-0462-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Deletion of the long arm of chromosome 20 is a recurrent abnormality observed in myelodysplastic syndromes (MDS) and in Philadelphia-chromosome-negative myeloproliferative disorders (MPD). Our objective was to characterize the deletion size among 38 MDS and MPD patients using fluorescence in situ hybridization (FISH) with bacterial artificial chromosome (BAC) probes and to define commonly deleted and retained regions on chromosome 20. Patients were distributed in three groups according to the World Health Organization classification: MDS (22 patients), MPD (12 patients) and myelodysplastic/myeloproliferative diseases (four patients). FISH with centromeric, subtelomeric, and unique sequence probes was performed to characterize the deletion whereas its size was delineated using BAC clones. All 38 deletions were found to be interstitial. A commonly deleted region was identified for each of the three groups; it varied from 6.62 to 10.4 Mb and showed considerable overlapping. Two commonly retained regions (CRR), also showing overlapping, were identified in all three groups, one in the centromeric region, the other in the telomeric region. The deletion size is highly variable, with no apparent recurrent breakpoint. The deletion may result in the loss of one or several tumor suppressor genes but the target genes remain unknown. Loss of genes plays an important part in the myeloid leukemic process associated with del(20q). However, genes located in the retained chromosomal regions may also play a role in the oncogenetic mechanisms.
引用
收藏
页码:537 / 544
页数:8
相关论文
共 49 条
[1]   MOLECULAR ANALYSIS OF CHROMOSOME 20Q DELETIONS ASSOCIATED WITH MYELOPROLIFERATIVE DISORDERS AND MYELODYSPLASTIC SYNDROMES [J].
ASIMAKOPOULOS, FA ;
WHITE, NJ ;
NACHEVA, E ;
GREEN, AR .
BLOOD, 1994, 84 (09) :3086-3094
[2]   Molecular genetics and cytogenetics of myeloproliferative disorders [J].
Bench, AJ ;
Nacheva, EP ;
Champion, KM ;
Green, AR .
BAILLIERES CLINICAL HAEMATOLOGY, 1998, 11 (04) :819-848
[3]   Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes [J].
Bench, AJ ;
Nacheva, EP ;
Hood, TL ;
Holden, JL ;
French, L ;
Swanton, S ;
Champion, KM ;
Li, J ;
Whittaker, P ;
Stavrides, G ;
Hunt, AR ;
Huntly, BJP ;
Campbell, LJ ;
Bentley, DR ;
Deloukas, P ;
Green, AR .
ONCOGENE, 2000, 19 (34) :3902-3913
[4]   A detailed physical and transcriptional map of the region of chromosome 20 that is deleted in myeloproliferative disorders and refinement of the common deleted region [J].
Bench, AJ ;
Aldred, MA ;
Humphray, SJ ;
Champion, KM ;
Gilbert, JGR ;
Asimakopoulos, FA ;
Deloukas, P ;
Gwilliam, R ;
Bentley, DR ;
Green, AR .
GENOMICS, 1998, 49 (03) :351-362
[5]   PROPOSALS FOR THE CLASSIFICATION OF THE MYELODYSPLASTIC SYNDROMES [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (02) :189-199
[6]   Prognostic significance of del(20q) in patients with hematological malignancies [J].
Brezinová, J ;
Zemanová, Z ;
Ransdorfová, S ;
Sindelárová, L ;
Sisková, M ;
Neuwirtová, R ;
Cermák, J ;
Michalová, K .
CANCER GENETICS AND CYTOGENETICS, 2005, 160 (02) :188-192
[7]   Deletion of chromosome 20q associated with hypereosinophilic syndrome - A report of two cases [J].
Brigaudeau, C ;
Liozon, E ;
Bernard, P ;
Trimoreau, F ;
Bordessoule, D ;
Praloran, V .
CANCER GENETICS AND CYTOGENETICS, 1996, 87 (01) :82-84
[8]  
CAMPBELL LJ, 1994, LEUKEMIA, V8, P67
[9]   HEMATOLOGIC MANIFESTATIONS ASSOCIATED WITH DELETIONS OF THE LONG ARM OF CHROMOSOME-20 [J].
DAVIS, MP ;
DEWALD, GW ;
PIERRE, RV ;
HOAGLAND, HC .
CANCER GENETICS AND CYTOGENETICS, 1984, 12 (01) :63-71
[10]  
DELANGE T, 1995, TELOMERES, P265